Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Cannabinoid
Sort By
Newest First
Sign in
1 / 1
1 / 1
Plant-Inspired Drug Discovery
Unlocking the Therapeutic Potential of Plant-Inspired Minimum Essential Mixtures
Andrea Small-Howard, Ph.D.
Gb Sciences, Inc.
PAO-08-022-CL-01
Sep 06, 2022
Cannabinoids
Kindeva and BOL Pharma Using Low Global Warming Potential (GWP) Propellant in Development of Inhaled Cannabinoid Products
Kindeva Drug Deliver
PR-M05-22-06
May 11, 2022
Parkinson's Disease Research
Gb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of Lethbridge
Gb Sciences, Inc.
PR-M04-22-08
Apr 12, 2022
Leveraging Biosynthesis to Create Pure Cannabinoids for Less
Maxim Mikheev, M.D., Ph.D.
Biomedican
PA1167
Dec 08, 2020
Cannabinoids
BIOMEDICAN Announces Successful Biosynthesis and Large-Scale Production of Rare Cannabinoids CBG/CBGA
Biomedican
PR-M11-20-010
Nov 12, 2020
Cannabinoids
Leveraging Biosynthetic Expertise to Access a Wide Portfolio of Cannabinoids
Michael Luther
Teewinot Life Sciences Corporation
PAP-Q3-19-CL-031
Oct 28, 2019
CBD
Regen BioPharma Successfully Treats Rheumatoid Arthritis Using Cannabidiol (CBD) Based Immune Modulatory Treatments
Regen BioPharma Inc.
PR-M10-19-NI-009
Oct 07, 2019
Strategic Partnership
Cronos Group Inc. Partners with Technion Research & Development Foundation for Cannabinoid-Based Skin Care Treatments
Cronos Group Inc.
PR-M10-18-NI-068
Oct 19, 2018
